As of 2024-12-12, the Relative Valuation of Adicet Bio Inc (ACET) is (26.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.02 USD, the upside of Adicet Bio Inc based on Relative Valuation is -2694.8%.
The range of the Relative Valuation is (25.89) - (27.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 24.9x | 18.3x |
| Forward P/E multiples | 12.5x - 19.4x | 18.7x |
| Fair Price | (25.89) - (27.78) | (26.47) |
| Upside | -2638.7% - -2823.8% | -2694.8% |
| Date | P/E |
| 2024-12-05 | -0.69 |
| 2024-12-04 | -0.71 |
| 2024-12-03 | -0.77 |
| 2024-12-02 | -0.78 |
| 2024-11-29 | -0.79 |
| 2024-11-27 | -0.78 |
| 2024-11-26 | -0.67 |
| 2024-11-25 | -0.63 |
| 2024-11-22 | -0.63 |
| 2024-11-21 | -0.64 |
| 2024-11-20 | -0.68 |
| 2024-11-19 | -0.72 |
| 2024-11-18 | -0.68 |
| 2024-11-15 | -0.66 |
| 2024-11-14 | -0.73 |
| 2024-11-13 | -0.80 |
| 2024-11-12 | -0.84 |
| 2024-11-11 | -0.88 |
| 2024-11-08 | -0.92 |
| 2024-11-07 | -0.93 |
| 2024-11-06 | -0.91 |
| 2024-11-05 | -0.92 |
| 2024-11-04 | -0.88 |
| 2024-11-01 | -0.87 |
| 2024-10-31 | -0.89 |
| 2024-10-30 | -0.95 |
| 2024-10-29 | -0.99 |
| 2024-10-28 | -1.00 |
| 2024-10-25 | -0.98 |
| 2024-10-24 | -0.99 |
| 2024-10-23 | -1.01 |
| 2024-10-22 | -1.06 |
| 2024-10-21 | -1.04 |
| 2024-10-18 | -1.01 |
| 2024-10-17 | -1.03 |
| 2024-10-16 | -1.04 |
| 2024-10-15 | -0.98 |
| 2024-10-14 | -0.96 |
| 2024-10-11 | -0.97 |
| 2024-10-10 | -0.98 |
| 2024-10-09 | -0.99 |
| 2024-10-08 | -1.00 |
| 2024-10-07 | -0.99 |
| 2024-10-04 | -0.99 |
| 2024-10-03 | -0.99 |
| 2024-10-02 | -1.04 |
| 2024-10-01 | -0.99 |
| 2024-09-30 | -1.01 |
| 2024-09-27 | -1.00 |
| 2024-09-26 | -0.98 |